Mulat Ayele | Clinical | Best Researcher Award

Posted on by ScienceFather

Mr. Mulat Ayele | Clinical | Best Researcher Award

Lecturer at Department of Midwifery, College of Health Science, Woldia University, Ethiopia

Summary:

Mr. Mulat Ayele is a distinguished clinical midwife and researcher with a Master of Science in Clinical Midwifery from the University of Gondar, Ethiopia, where he graduated in 2022 as the top scorer. He also holds a Bachelor of Science in Midwifery from Woldia University, where he excelled academically. Mr. Ayele has a strong research background, with multiple publications in reputable, peer-reviewed journals, focusing on obstetrics and gynecology. Currently, he serves as a lecturer and clinician at Woldia University, where he is actively involved in teaching, clinical practice, and research. His expertise lies in maternal and perinatal outcomes associated with obstetric interventions, particularly in low- and middle-income countries.

Profile:

Education:

Mr. Mulat Ayele holds a Master of Science in Clinical Midwifery from the University of Gondar, Ethiopia, where he graduated in July 2022 with an outstanding GPA of 3.97/4.0, making him the top scorer in his cohort. His thesis, titled “Caesarean Delivery and Associated Factors Among Women Who Give Birth in North-West Amhara Referral Hospitals by Using Robson’s Group Ten Classification,” received an excellent grade, reflecting his deep expertise in the field. Prior to this, he earned a Bachelor of Science in Midwifery from Woldia University, Ethiopia, in July 2017, also graduating as the top scorer in his department with a GPA of 3.94/4.0. His research project on “Knowledge on Obstetric Danger Signs of Pregnancy and Associated Factors Among Pregnant Women Who Attend ANC in Alamata General Hospital, Southern Tigray, Ethiopia” was highly commended, further demonstrating his academic excellence and commitment to advancing maternal and child health.

Professional Experience:

Mr. Mulat Ayele has accumulated extensive professional experience in both academic and clinical settings. He is currently serving as a Lecturer and Clinician at Woldia University since July 2022, where he teaches, supervises clinical practice in hospitals, conducts research, and engages in community service. Prior to this, he worked as an Assistant Lecturer at Woldia University from July 2018 to July 2019 and as a Graduate Assistant from July 2017 to July 2018. During his tenure, Mr. Ayele has been actively involved in various departmental roles and committees, consistently receiving high job evaluation scores. His professional journey is marked by his commitment to advancing maternal and perinatal health, particularly in the context of obstetric interventions in low- and middle-income countries.

Research Interests:

Mr. Mulat Ayele’s research interests are deeply rooted in the field of maternal and perinatal health, with a specific focus on the impact of obstetric interventions in low- and middle-income countries. As a clinical midwife, he is particularly interested in exploring the multifaceted factors associated with the increased uptake of caesarean deliveries and other obstetric interventions, as well as their short- and long-term outcomes for both mothers and newborns. Mr. Ayele is also passionate about qualitative research, which allows him to examine the experiences and perceptions of healthcare providers and the communities they serve. His dedication to improving maternal and perinatal outcomes drives his commitment to research that can make a significant difference in healthcare practices and policies in resource-limited settings.

Conclution:

Mr. Mulat Ayele’s academic background, research achievements, and professional experience make him a highly suitable candidate for the “Research for Best Researcher Award.” His work in maternal and perinatal health, particularly in the context of low- and middle-income countries, is not only relevant but also impactful, positioning him as a deserving recipient of such recognition.

Publication Top Noted:

  • Nonpneumatic anti-shock garment utilization for obstetric hemorrhage management and its predictors among obstetric care providers in Ethiopia: a systematic review and meta-analysis
    • Journal: BMC Health Services Research
    • Year: 2024
    • Volume: 24(1), Article: 874
    • Authors: Lake, E.S., Ayele, M., Yilak, G., Zemariam, A.B., Kumie, G.
  • Magnitude and associated factors of unmet need for family planning among reproductive-aged women in Ethiopia: An umbrella review
    • Journal: PLoS ONE
    • Year: 2024
    • Volume: 19(8 August), Article: e0308085
    • Authors: Ayele, M., Yilak, G., Alamrew, A., Lake, E.S., Tilahun, B.D.
  • Prevalence of ineffective breastfeeding techniques and its associated factors among breastfeeding mothers in Ethiopia: A systematic review and meta-analysis
    • Journal: PLoS ONE
    • Year: 2024
    • Volume: 19(6 June), Article: e0303749
    • Authors: Yilak, G., Tilahun, B.D., Abate, B.B., Ayele, M., Belay, A.S.
  • Analysis of caesarean delivery rates using Robson ten group classification system in North West Amhara referral hospitals, Ethiopia, 2022: A cross-sectional study
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24, Article: e02237
    • Authors: Ayele, M., Berta, M., Zewdie, A., Lake, E.S., Belayneh, M.
  • Surgical site infection following cesarean section and its predictors in Ethiopia: A systematic review and meta-analysis
    • Journal: PLoS ONE
    • Year: 2024
    • Volume: 19(3 March), Article: e0296767
    • Authors: Lake, E.S., Alamrew, A., Belay, W.S., Abita, Z., Ayele, M.
  • Exploring the perceptions of health service providers and adolescents on the utilization of adolescent sexual and reproductive health services in Tikur, 2023: A qualitative study
    • Journal: SAGE Open Medicine
    • Year: 2024
    • Volume: 12
    • Authors: Tilahun, B.D., Yilak, G., Amena, S., Abebe, G.K., Ayele, M.
  • Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis
    • Journal: BMC Public Health
    • Year: 2023
    • Volume: 23(1), Article: 1369
    • Authors: Zewdie, A., Kasahun, A.W., Habtie, A., Gashaw, A., Ayele, M.
  • Determinants of evidence-based practice among health care professionals in Ethiopia: A systematic review and meta-analysis
    • Journal: PLoS ONE
    • Year: 2023
    • Volume: 18(11 November), Article: e0293902
    • Authors: Zewdie, A., Ayele, M., Melis, T., Kasahun, A.W.

Guodong Liang | Medicinal | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. Guodong Liang | Medicinal | Young Scientist Award

Senior Engineer at Inner Mongolia Medical University, China

Summary:

Assoc Prof Dr Guodong Liang is a senior engineer and master tutor at the College of Pharmacy, Inner Mongolia Medical University. Specializing in peptide-based antiviral research, Dr. Liang completed his Bachelor’s and Master’s degrees at Shenyang Pharmaceutical University in 2012 and 2015, respectively, and earned his Ph.D. from the Beijing Institute of Pharmacology and Toxicology in 2018. His research focuses on innovative peptide fusion inhibitors for treating viral infections, including HIV-1 and SARS-CoV-2. Notable for his contributions to peptide science, Dr. Liang has published extensively, holds a U.S. patent, and has received funding from various prestigious programs.

 

Profile:

Education:

Assoc Prof Dr Guodong Liang earned his Bachelor’s degree in Pharmacy from Shenyang Pharmaceutical University in 2012. He continued his studies at the same institution, obtaining a Master’s degree in Pharmaceutical Sciences in 2015. Further advancing his academic career, he completed his Ph.D. in Pharmacology and Toxicology at the Beijing Institute of Pharmacology and Toxicology in 2018. His educational background has provided a strong foundation for his research in peptide-based antiviral strategies.

Professional Experience:

Assoc Prof Dr Guodong Liang is a senior engineer and master tutor at the College of Pharmacy, Inner Mongolia Medical University. In this role, he leads research and teaching initiatives, focusing on peptide-based antiviral therapies. Prior to his current position, Dr. Liang has accumulated extensive experience in peptide research and development. His expertise encompasses the design of peptide fusion inhibitors and contributions to significant research projects funded by various programs, including the Inner Mongolia Natural Science Foundation and Inner Mongolia Medical University. His professional background reflects a commitment to advancing antiviral research and educating the next generation of scientists.

Research Interests:

Assoc Prof Dr Guodong Liang’s research interests are centered around peptide-based antiviral therapies. His work primarily focuses on the development and application of peptide fusion inhibitors to combat viral infections. Notable areas of his research include the design of isopeptide bond bundling superhelixes and their application in creating inhibitors against viruses such as HIV-1 and SARS-CoV-2. Dr. Liang explores innovative methods for developing broad-spectrum antiviral peptide drugs, aiming to enhance the efficacy of treatments for various viral diseases. His research integrates advanced peptide chemistry with practical antiviral applications, contributing to the field of pharmaceutical science.

Skills:

Assoc Prof Dr Guodong Liang possesses a robust skill set in peptide chemistry and antiviral drug development. His expertise includes designing and synthesizing peptide-based fusion inhibitors, with a focus on creating isopeptide bond bundling superhelixes for antiviral applications. Dr. Liang is proficient in advanced techniques for peptide analysis and evaluation, including structural and functional assessments of peptide interactions with viral proteins. His skills extend to securing and managing research funding, conducting collaborative projects, and publishing high-impact scientific papers. With a strong foundation in pharmacology and toxicology, Dr. Liang effectively translates complex scientific concepts into practical antiviral solutions.

Conclution:

Dr. Liang’s pioneering work in peptide-based antiviral research, evidenced by his impactful publications, patents, and innovative projects, demonstrates his significant contributions to the field. His research not only advances the design of targeted antiviral therapies but also lays the groundwork for developing broad-spectrum antiviral drugs, marking him as a leading candidate for the Research for Young Scientist Award.

Publication Tob Noted:

A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity

  • Authors: Li, Y.-Y., Liang, G.-D., Chen, Z.-X., Liu, S.-W., Yang, J.
  • Journal: Acta Pharmacologica Sinica, 2024

Isopeptide Bond Bundling Superhelix for Designing Antivirals against Enveloped Viruses with Class I Fusion Proteins: A Review

  • Authors: Na, H., Liang, G., Lai, W.
  • Journal: Current Pharmaceutical Biotechnology, 2023, 24(14), pp. 1774–1783

Hipponorterpenes A and B, two new 14-noreudesmane-type sesquiterpenoids from the juice of Hippophae rhamnoides

  • Authors: Zhang, X.-L., Na, H.-Y., Li, P.-S., Liang, G.-D., Hua, H.-M.
  • Journal: Phytochemistry Letters, 2022, 52, pp. 82–86

De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery

  • Authors: Wang, C., Zhao, L., Xia, S., Jiang, S., Liu, K.
  • Journal: Journal of Medicinal Chemistry, 2018, 61(19), pp. 8734–8745

 

Xichun Hu | Medicine | Best Researcher Award

Posted on by ScienceFather

Prof. Xichun Hu | Medicine | Best Researcher Award

Professor at Fudan University Shanghai Cancer Center, China

Summary:

Prof. Xichun Hu is a renowned oncologist specializing in oncology treatment. He was born on December 14, 1965, in Yancheng, Jiangsu Province, China. Prof. Hu earned his Bachelor of Medicine from Suzhou Medical College in 1988, followed by a Master of Oncology from Shanghai Medical University in 1991. He completed his Doctorate at The University of Hong Kong in 2001. His academic journey includes advanced training in hospital management and clinical trials from prestigious institutions like the Vienna School of Clinical Research and Mayo Clinic.

 

Profile:

Education:

Prof. Xichun Hu’s educational background is distinguished and extensive. He completed his Bachelor of Medicine at Suzhou Medical College from September 1983 to July 1988. He pursued further specialization in oncology by obtaining a Master of Oncology from Shanghai Medical University Graduate School between September 1988 and July 1991. Prof. Hu then advanced his expertise with a Doctorate from The University of Hong Kong, where he studied from April 1998 to November 2001. His commitment to continuous learning is evident from his participation in advanced training programs, including the Hospital Management Advanced Training Program for Middle-level Cadres at Cancer Otolaryngology Hospital in 2006, and Clinical Trials in Oncology at Vienna School of Clinical Research, Shanghai in 2006. Additionally, he underwent Clinical Trials Training at Mayo Clinic, USA, in 2007, where he was awarded the ICRE fellow by the National Foundation for Cancer Research, further showcasing his dedication to advancing his knowledge and skills in the field of oncology.

Professional Experience:

Prof. Xichun Hu’s extensive professional career in oncology spans several decades. He began as a Resident Physician at Shanghai Medical University Cancer Hospital from July 1988 to June 1994, where he honed his clinical skills. He was promoted to Attending Physician at the same institution from June 1994 to March 1998. His career progressed as he took on the role of Attending Physician at Fudan University Cancer Hospital from December 2001 to November 2002. Prof. Hu was subsequently appointed Associate Chief Physician at Fudan University Cancer Hospital, serving from November 2002 to April 2008. He also held the position of Executive Vice President at the hospital’s Minhang Branch from December 2006 to March 2008. Since April 2008, Prof. Hu has been a Chief Physician and Professor at Fudan University Cancer Hospital, where he continues to lead and innovate in oncology treatment. His roles have included Doctoral Supervisor (2012–present), Deputy Director of the Chemotherapy Department (February 2006 – December 2014), Acting Deputy Director of the Oncology Department (December 2014 – March 2016), and Executive Deputy Director of the Clinical Trial Institution (March 2016 – present). He has been the Director of the Oncology Department since June 2016, shaping the future of cancer care through his leadership and expertise.

Research Interests:

Prof. Xichun Hu’s research interests are deeply rooted in oncology, with a focus on advancing the treatment and understanding of breast cancer. His work explores various dimensions of cancer biology and therapy, including hormone receptor-positive and HER2-negative advanced breast cancer, and the heterogeneity between primary and metastatic cancer. Prof. Hu investigates the efficacy of novel treatments such as Pyrotinib plus capecitabine for trastuzumab-resistant HER2-positive breast cancer. His research also delves into immune resistance mechanisms, particularly in triple-negative breast cancer, and the role of chromatin remodeling molecules like ARID1A in metastatic heterogeneity. Additionally, he is engaged in clinical and preclinical studies of new therapies, such as the highly selective HER2 inhibitor DZD1516, and the novel anti-PD-L1 monoclonal antibody MSB2311. Prof. Hu’s research aims to improve early diagnosis, treatment strategies, and survival outcomes for breast cancer patients, particularly those with recurrent and metastatic forms of the disease.

Publications:

Prof. Hu has authored 305 papers, including key publications in top-tier SCI journals. His research covers critical areas such as hormone receptor-positive breast cancer, HER2-low breast cancer heterogeneity, and novel cancer therapies. His work, including recent publications in prestigious journals like Cancer Med and BMC Med, highlights his ongoing contributions to advancing oncology.

Conclusion:

Prof. Xichun Hu’s outstanding qualifications, numerous awards, influential professional experience, dedication to teaching, and extensive publication record collectively demonstrate his exceptional impact on the field of oncology. His continuous contributions to cancer research and patient care make him a fitting candidate for the Research for Best Researcher Award.

Publication Tob Noted:

GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases

Journal: Scientific Data

Date: June 10, 2023

DOI: 10.1038/s41597-023-02257-1

Contributors: Ziteng Li, Hena Zhang, Qin Li, Wanjing Feng, Xiya Jia, Runye Zhou, Yi Huang, Yan Li, Zhixiang Hu, Xichun Hu, et al.

Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial

Journal: Acta Pharmaceutica Sinica B

Date: May 2023

DOI: 10.1016/j.apsb.2023.02.001

Contributors: Binghe Xu, Qingyuan Zhang, Xichun Hu, Qing Li, Tao Sun, Wei Li, Quchang Ouyang, Jingfen Wang, Zhongsheng Tong, Min Yan, et al.

Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases

Journal: Cancer Medicine

Date: January 2023

DOI: 10.1002/cam4.4973

Contributors: Peng Qi, Yifeng Sun, Xin Liu, Sheng Wu, Yixin Wo, Qinghua Xu, Qifeng Wang, Xichun Hu, Xiaoyan Zhou

Phase I Study of A166, a Novel Antibody-Drug Conjugate in Advanced HER2-expressing Solid Tumors

Type: Preprint

Date: November 1, 2022

DOI: 10.21203/rs.3.rs-2179560/v1

Contributors: Xichun Hu, Jian Zhang, Rujiao Liu, Shuiping Gao, Wenhua Li, Yang Chen, Yanchun Meng, Chang Liu, Wenyue Jin, Shuli Yi, et al.

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

Journal: Journal of Clinical Oncology

Date: March 1, 2021

DOI: 10.1200/JCO.20.02712

Contributors: Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, Qi Li, Nong Xu, Xi-Chun Hu, Wangjun Liao, Yi Jiang, Xiao-Yan Lin, Qing-yuan Zhang, et al.

Dagne Dinagde | Health Science | Excellence in Research

Posted on by ScienceFather

Mr. Dagne Dinagde | Health Science | Excellence in Research

Lecturer at Mattu University, Ethiopia

Summary:

Mr. Dagne Dinagde is a distinguished midwifery professional and academic, currently holding a Bachelor of Science degree in Health Science with a specialization in Midwifery from Mattu University, where he graduated with a remarkable CGPA of 3.95 in 2019. He further advanced his expertise by obtaining a Master of Science degree in Clinical Midwifery from Arba Minch University in 2023, graduating with distinction and a CGPA of 3.58. Mr. Dinagde has an impressive research portfolio with 14 publications in health science, serving as the principal investigator for 11 of them. He has also contributed to academia as a lecturer at Mattu University for two years. His professional achievements have been recognized with certificates and recommendation letters from various esteemed institutions, including the Oromia Regional Bureau, Arba Minch General Hospital, and Mattu University’s Gender and HIV/AIDS Issues department.

Profile:

Education:

Mr. Dagne Dinagde obtained his Bachelor of Science degree in Health Science with a specialization in Midwifery from Mattu University on June 27, 2019, achieving an outstanding CGPA of 3.95. He then pursued a Master of Science degree in Clinical Midwifery at Arba Minch University, which he completed with distinction on May 11, 2023, earning a CGPA of 3.58. His master’s research thesis received a ‘Very Good’ rating, equivalent to an A- grade (84%).

Professional Experience:

Mr. Dagne Dinagde has accumulated valuable professional experience in the field of midwifery. He has served as a lecturer at Mattu University for two years, where he contributed to the academic development of students. His role involved teaching, mentoring, and participating in various academic activities to enhance the quality of education in health sciences.

Research Interest:

Mr. Dagne Dinagde’s research interests are centered around various areas of health science, particularly in midwifery. His focus includes improving clinical practices in midwifery, enhancing maternal and child health outcomes, and exploring innovative approaches in clinical midwifery. He is also dedicated to conducting research that addresses public health challenges and contributes to the advancement of healthcare services. Mr. Dinagde has actively participated in numerous research projects, with a strong emphasis on evidence-based practices and healthcare improvement.

Publication:

 

 

Wolnei Caumo | Medical award | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Wolnei Caumo, Medical Award, Best Researcher Award

Professor at UFRGS, Brazil

Prof. Dr. Wolnei Caumo is a distinguished expert in the fields of anesthesia, pain management, and clinical research. As the Director of the Pain & Neuromodulation Laboratory at Hospital de Clínicas de Porto Alegre (HCPA) and Full Professor of Anesthesia and Pain at the Medical School of Universidade Federal do Rio Grande do Sul (UFRGS) in Porto Alegre, Brazil, he has made significant contributions to advancing the understanding and treatment of chronic pain conditions. Dr. Caumo’s research focuses on neurophysiological markers of pain processing, biomarkers of neuroplasticity in chronic pain, and therapeutic interventions such as pharmacological and non-invasive brain stimulation techniques. He is renowned for his dedication to education and mentorship, guiding numerous students and research fellows in pain management practices. Dr. Caumo’s work has earned him widespread recognition and respect, and he continues to lead innovative research efforts aimed at improving the lives of individuals living with chronic pain.

Profile:

Education:

  • M.D. from Universidade Federal de Pelotas, Brazil (1992)
  • Residency in Anesthesia at Hospital de Clínicas de Porto Alegre, Brazil (1994)
  • M.Sc. in Medicine from Universidade Federal do Rio Grande do Sul, Brazil (1997)
  • Specialist in Pain and Palliative Medicine from Universidade Federal do Rio Grande do Sul, Brazil (2000)
  • Ph.D. in Medicine with specialization in Pain from Universidade Federal do Rio Grande do Sul, Brazil (2001)
  • Clinical Research Course from Harvard Medical School, USA (2011)

Professional Experience:

Prof. Dr. Wolnei Caumo holds several prominent positions in the field of anesthesia, pain management, and research. He is currently serving as a Full Professor of Anesthesia and Pain at the Medical School of Universidade Federal do Rio Grande do Sul in Porto Alegre, Brazil, a position he has held since 2003. Additionally, he serves as the Head of Service in Pain and Palliative Care at Hospital de Clínicas de Porto Alegre, where he has been contributing since 2017. Dr. Caumo is also the Director of the Laboratory of Pain & Neuromodulation at the same hospital, a role he has held since 2009. Over the years, he has been actively involved in coordinating various academic programs, including the Specialized Medical Care for Pain and Palliative Medicine Course and the Graduate Program in Medical Sciences at Universidade Federal do Rio Grande do Sul. Furthermore, he has been a Coordinator of the Center and teacher assistance of the Course in Principles and Practice of Clinical Research at Harvard Medical School since 2012. Dr. Caumo’s dedication to education and research in pain management has made him a respected figure in the field, both nationally and internationally.

Research Interest:

Prof. Dr. Wolnei Caumo’s research interests primarily revolve around pain management and neuromodulation approaches. He is particularly focused on investigating the neurophysiological mechanisms underlying chronic pain processing, including central sensitization and cortical excitability. Dr. Caumo’s research aims to identify biomarkers of neuroplasticity in musculoskeletal chronic pain conditions and explore therapeutic interventions to counteract maladaptive neuroplasticity. Additionally, he is interested in the therapeutic potential of non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), in modulating pain perception and improving clinical outcomes in patients with chronic pain syndromes. His work also encompasses the evaluation of pharmacological interventions and the development of personalized treatment approaches based on individual neurobiological profiles. Overall, Prof. Dr. Wolnei Caumo’s research endeavors contribute to advancing our understanding of pain mechanisms and developing innovative strategies for pain management.

Publication Top Noted:

“Cross-sectional and longitudinal analysis of conditioned pain modulation and pain in fibromyalgia: CPM as an effect modifier of pain changes over time”:

  • Authors: Castelo-Branco, L., Pacheco-Barrios, K., Cardenas-Rojas, A., Caumo, W., Fregni, F.
  • Journal: Physiotherapy Research International
  • Year: 2024
  • Volume: 29
  • Issue: 2
  • Pages: e2072

“Impact of multiple-session home-based transcranial direct current stimulation (M-HB-tDCS) on eating behavior in fibromyalgia: A factorial randomized clinical trial”:

  • Authors: Jornada, M.N.D., Antunes, L.C., Alves, C., P Silva, D., Caumo, W.
  • Journal: Brain Stimulation
  • Year: 2024
  • Volume: 17
  • Issue: 2
  • Pages: 152–162

“Efficacy of Home-Based Transcranial Direct Current Stimulation Over the Primary Motor Cortex and Dorsolateral Prefrontal Cortex in the Disability Due to Pain in Fibromyalgia: A Factorial Sham-Randomized Clinical Study”:

  • Authors: Caumo, W., Lopes Ramos, R., Vicuña Serrano, P., LS Torres, I., Fregni, F.
  • Journal: Journal of Pain
  • Year: 2024
  • Volume: 25
  • Issue: 2
  • Pages: 376–392

“Troponin elevation as a marker of short deterioration and one-year death in a high-risk surgical patient cohort in a low and middle-income country setting: a postoperative approach to increase surveillance”:

  • Authors: Stahlschmidt, A., Passos, S.C., Dornelles, D.D., Caumo, W., Ferreira, M.
  • Journal: Canadian Journal of Anesthesia
  • Year: 2023
  • Volume: 70
  • Issue: 11
  • Pages: 1776–1788

“Transcranial Direct Current Stimulation (tDCS) Promotes state-dependent Effects on Neuroinflammatory and Behavioral Parameters in rats Chronically Exposed to Stress and a Hyper-Palatable Diet”:

  • Authors: de Castro, J.M., de Freitas, J.S., Stein, D.J., Caumo, W., Torres, I.L.S.
  • Journal: Neurochemical Research
  • Year: 2023
  • Volume: 48
  • Issue: 10
  • Pages: 3042–3054

“Preemptive transcranial direct current stimulation induces analgesia, prevents chronic inflammation and fibrosis, and promotes tissue repair in a rat model of postoperative pain”:

  • Authors: Zancanaro, M., Stein, D.J., Lopes, B.C., Caumo, W., Torres, I.L.S.
  • Journal: Neuroscience Letters
  • Year: 2023
  • Volume: 813
  • Pages: 137407